See also this year's filing and all EDGAR filings for this company.
PDF Report 0000886163_2020_LIGAND_PHARMACEUTICALS_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000886163, LIGAND PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,123,645,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 305,677,000 |
| 2 | PropertyPlantAndEquipmentNet | 7,185,000 |
| 3 | remainder_Assets | 58,408,000 |
| 4 | LiabilitiesCurrent | 17,002,000 |
| 5 | LiabilitiesNoncurrent | 32,450,000 |
| 6 | remainder_Liabilities | 678,231,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 41,884,000 |
| 9 | ResearchAndDevelopmentExpense | 55,908,000 |
| 10 | remainder_Expenses | 195,548,000 |
| 11 | remainder_Revenues | 120,282,000 |
| 12 | remainder_NetIncome | 802,360,000 |
| 13 | remainder_ComprehensiveNetIncome | 808,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,494,915,000 |
| 1 | Liabilities | 727,683,000 |
| 2 | Expenses | 293,340,000 |
| 3 | Revenues | 120,282,000 |
| 4 | StockholdersEquity | 767,232,000 |
| 5 | NetIncome | 629,302,000 |
| 6 | ComprehensiveNetIncome | 629,706,000 |
| 7 | BaseVar | 1,719,694,000 |
| 8 | EconomicCapitalRatio | 1.75 |
Edgar->Model Mapping
Feature Distribution
Change over Time
